Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 1
1981 1
1982 2
1983 1
1984 3
1985 1
1987 4
1988 3
1989 2
1990 3
1991 2
1992 4
1993 6
1994 1
1995 5
1996 6
1997 8
1998 2
1999 1
2000 2
2001 2
2002 7
2003 4
2004 3
2005 3
2006 1
2007 6
2008 4
2009 9
2010 6
2011 7
2012 9
2013 14
2014 8
2015 13
2016 16
2017 9
2018 20
2019 16
2020 10
2021 7
2022 3
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

220 results
Results by year
Filters applied: . Clear all
Page 1
Hyperkalemia in chronic kidney disease.
Watanabe R. Watanabe R. Rev Assoc Med Bras (1992). 2020 Jan 13;66Suppl 1(Suppl 1):s31-s36. doi: 10.1590/1806-9282.66.S1.31. Rev Assoc Med Bras (1992). 2020. PMID: 31939533 Free article. Review.
Controversies in Management of Hyperkalemia.
Long B, Warix JR, Koyfman A. Long B, et al. J Emerg Med. 2018 Aug;55(2):192-205. doi: 10.1016/j.jemermed.2018.04.004. Epub 2018 May 3. J Emerg Med. 2018. PMID: 29731287 Review.
Dialysis is the most efficient means to enable removal of excess K+. Loop and thiazide diuretics can also be useful. Sodium polystyrene sulfonate is not efficacious. New medications to promote gastrointestinal K+ excretion, which include patiromer and sodium zirconium cycl …
Dialysis is the most efficient means to enable removal of excess K+. Loop and thiazide diuretics can also be useful. Sodium polystyrene
Patiromer for the treatment of hyperkalemia.
Colbert GB, Patel D, Lerma EV. Colbert GB, et al. Expert Rev Clin Pharmacol. 2020 Jun;13(6):563-570. doi: 10.1080/17512433.2020.1774363. Epub 2020 Jun 8. Expert Rev Clin Pharmacol. 2020. PMID: 32511052 Review.
Recently newer oral potassium-binding agents have been approved for clinical use, as an alternative to the decades long use of sodium polystyrene sulfonate. This review will focus on the patiromer and its use in reducing hyperkalemia. AREAS COVERED: Pubmed was used to sear …
Recently newer oral potassium-binding agents have been approved for clinical use, as an alternative to the decades long use of sodium pol
Potassium Binders for Hyperkalemia in Chronic Kidney Disease-Diet, Renin-Angiotensin-Aldosterone System Inhibitor Therapy, and Hemodialysis.
Palmer BF. Palmer BF. Mayo Clin Proc. 2020 Feb;95(2):339-354. doi: 10.1016/j.mayocp.2019.05.019. Epub 2019 Oct 23. Mayo Clin Proc. 2020. PMID: 31668450 Free article. Review.
Recently, 2 K(+)-binding agents were approved for the treatment of hyperkalemia: sodium zirconium cyclosilicate and patiromer. These agents offer alternatives to sodium polystyrene sulfonate, which is associated with serious gastrointestinal adverse effects. …
Recently, 2 K(+)-binding agents were approved for the treatment of hyperkalemia: sodium zirconium cyclosilicate and patiromer. These agents …
Potassium binders for chronic hyperkalaemia in people with chronic kidney disease.
Natale P, Palmer SC, Ruospo M, Saglimbene VM, Strippoli GF. Natale P, et al. Cochrane Database Syst Rev. 2020 Jun 26;6(6):CD013165. doi: 10.1002/14651858.CD013165.pub2. Cochrane Database Syst Rev. 2020. PMID: 32588430 Free PMC article.
BACKGROUND: Hyperkalaemia is a common electrolyte abnormality caused by reduced renal potassium excretion in patients with chronic kidney diseases (CKD). Potassium binders, such as sodium polystyrene sulfonate and calcium polystyrene sulfonate, are widely used but m …
BACKGROUND: Hyperkalaemia is a common electrolyte abnormality caused by reduced renal potassium excretion in patients with chronic kidney di …
[Kayexalate].
Gervais C, de Longraye J. Gervais C, et al. Soins. 1984 Dec;(443-444):I-II. Soins. 1984. PMID: 6570569 French. No abstract available.
Kayexalate-Induced Colonic Pseudotumor.
Chatila AT, Bilal M, Merwat S. Chatila AT, et al. Clin Gastroenterol Hepatol. 2019 Jun;17(7):e73. doi: 10.1016/j.cgh.2018.03.032. Epub 2018 Mar 30. Clin Gastroenterol Hepatol. 2019. PMID: 29609060 No abstract available.
Drug-induced injury in the gastrointestinal tract.
Panarelli NC. Panarelli NC. Semin Diagn Pathol. 2014 Mar;31(2):165-75. doi: 10.1053/j.semdp.2014.02.007. Epub 2014 Feb 11. Semin Diagn Pathol. 2014. PMID: 24815941 Review.
Abnormalities of the gastrointestinal tract due to drug-induced injuries are common and often have important clinical consequences. Medications may cause damage by direct corrosive effects on mucosae or by alter processes, mucosal immunity, and local environmental conditio …
Abnormalities of the gastrointestinal tract due to drug-induced injuries are common and often have important clinical consequences. Medicati …
Saltpeter ingestion.
Sporer KA, Mayer AP. Sporer KA, et al. Am J Emerg Med. 1991 Mar;9(2):164-5. doi: 10.1016/0735-6757(91)90183-k. Am J Emerg Med. 1991. PMID: 1994946
Heparin-induced hyperkalemia.
Edes TE, Sunderrajan EV. Edes TE, et al. Arch Intern Med. 1985 Jun;145(6):1070-2. Arch Intern Med. 1985. PMID: 4004433
220 results